Loading...

ENG KOR

KB STAR ETF 로고

홈으로 이동

KOR ENG

ETF Finder

Home Product Lineup ETF Finder Product Details
Domestic
Equity Passive

RISE Healthcare (253280)

Update : 2026.02.10

NAV

18,336KRW

+705.51상승 (4%)

Market Price per share (KRW)

18,365KRW

+705상승 (3.99%)

※ t-1 last price

trading volume

55,887shares

AUM

KRW 12.8billion

Share it

RISE Healthcare (253280)

Overview Performance Holdings

KEY POINT

Invest in domestic healthcare companies (medical equipment and services, bio, pharmaceutical)

KEY POINT

Invest in selected healthcare companies based on financial conditions among the top 500 companies by market capitalization of the KOSPI and KOSDAQ markets

Basic information

Download trading information

Update : 2026.02.10
ETF name(Code), Benchmark Index, Inception date, creation unit, Net Asset (KRW 0.1 billion), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name (code) Benchmark Index Inception date Creation Unit AUM (KRW)
KB RISE HealthCare ETF
(253280) 		FnGuide HealthCare Index 2016.09.23 50,000 12,835,441,030
Trustee Market Price per share (KRW) NAV Trading Volume (shares)
하나은행 18,365
※ t-1 last price 		18,336 55,887
authorized participant, Liquidity provider table
Total Expense Ratio Distribution Frequency
Year 0.05% (Designated participating company : 0.001%, Collective investment : 0.029%, trust : 0.01%, General affairs : 0.01%) Last business day of January, April, July and October, and end of accounting period (occasional payment)
Authorized Participants Liquidity Providers
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities
ETF name(Code), Benchmark Index, Inception date, creation unit, AUM(0.1 billion) (KRW), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name(Code) Benchmark Index
KB RISE HealthCare ETF

(253280) 		FnGuide HealthCare Index
Inception date Creation Unit
2016.09.23 50,000
AUM(0.1 billion) (KRW) Trustee
12,835,441,030 하나은행
Market Price per share (KRW) iNAV per share (KRW)
18,365
※ t-1 last price 		18,336
Trading Volume (shares)
55,887
authorized participant, Liquidity provider table
Total Expense Ratio
Year 0.05% (Designated participating company : 0.001%, Collective investment : 0.029%, trust : 0.01%, General affairs : 0.01%)
Distribution Frequency
Last business day of January, April, July and October, and end of accounting period (occasional payment)
Authorized Participants
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities
Liquidity Providers
KB Securities, Meritz Securities, NH Investment & Securities, Kiwoom Securities, Samsung Securities

Index Introduction

The FnGuide Healthcare Index is a market capitalization weighted index. The index selects stocks that satisfy financial and management soundness criteria out of the universe of stocks come under the medical sector in the MKF 500.

View detailed index information

TOP 10 Holdings

Update : 2026-02-10
Rank , Name, proportion table
Rank Name Weight (%)
1 Celltrion 11.31
2 SAMSUNG BIOLOGICS 9.24
3 ABL Bio 8.25
4 SCD 7.83
5 Alteogen 7.83
6 HLB 6.47
7 Yuhan 6.24
8 LCB 4.88
9 HanmiPharm 3.68
10 SKBP 3.12

proportion by sectors

*The proportion of investment stocks

Update : 2026.02.10
Rank , Name, proportion table
Rank Name Weight (%)
1 Healthcare 100.00

Dividend payment data

· Payable date of dividend payment 3 years.
Rule of Dividend payment, Payable date of dividend payment, dividend per share (KRW) table
Rule of Dividend payment Payable date of dividend payment dividend per share (KRW)
2025-04-30 2025-05-07 20
2023-04-28 2023-05-03 16
2022-04-29 2022-05-03 60

Performance

performance

excel download

Update : 2026-02-10

 (as of Oct : %)

The result of above Net Asset Value performance is the rate of return assuming distribution reinvestment.

classification, 1Month, 3Month, 6Month, 1year, 3year, YTD (Year to date), Since inception, NAV, Benchmark Index, Outperformance table
classification 1Month 3Month 6Month 1year 3year YTD
(Year to date)		 Since
inception
NAV 1.83 15.40 24.24 21.33 73.86 8.90 80.79
Benchmark Index 1.89 15.68 24.71 21.82 74.91 9.15 82.72
Outperformance -0.06 -0.28 -0.48 -0.5 -1.05 -0.25 -1.93

daily Performance

excel download

-
search
date, market price (KRW), NAV (KRW)
date Market price (KRW) NAV (KRW) Standard Tax Base Price (KRW)
closing price Daily Return(%) closing price Daily Return(%)
2026.02.09 18,365 3.992상승 18,336.34 4.001상승 10,369.11
2026.02.06 17,660 -2.295하락 17,630.91 -2.255하락 10,369.24
2026.02.05 18,075 -2.926하락 18,037.66 -3.324하락 10,368.51
2026.02.04 18,620 -0.454하락 18,657.97 -0.014하락 10,365.84
2026.02.03 18,705 3.714상승 18,660.65 3.715상승 10,365.89
2026.02.02 18,035 -3.401하락 17,992.16 -3.517하락 10,365.93
2026.01.30 18,670 -4.938하락 18,648.12 -4.815하락 10,366.05
2026.01.29 19,640 1.054상승 19,591.6 1.019상승 10,366.09
2026.01.28 19,435 3.212상승 19,393.86 2.650상승 10,366.13
2026.01.27 18,830 0.319상승 18,893.11 0.795상승 10,366.17
2026.01.26 18,770 6.045상승 18,743.92 5.793상승 10,366.22
2026.01.23 17,700 5.357상승 17,717.49 5.405상승 10,366.35
2026.01.22 16,800 1.664상승 16,808.9 1.950상승 10,366.39
2026.01.21 16,525 -5.598하락 16,487.39 -5.919하락 10,366.44
2026.01.20 17,505 0.200상승 17,524.81 0.360상승 10,366.48
2026.01.19 17,470 -1.075하락 17,461.83 -1.314하락 10,366.53
2026.01.16 17,660 1.523상승 17,694.57 1.583상승 10,366.67
2026.01.15 17,395 0.288상승 17,418.7 0.421상승 10,366.72
2026.01.14 17,345 -1.448하락 17,345.55 -1.411하락 10,366.77
2026.01.13 17,600 -1.095하락 17,593.88 -1.117하락 10,366.81
2026.01.12 17,795 -0.752하락 17,792.71 -1.190하락 10,366.86

Holdings

search
Download holdings data
Name, Ticker, Number. of shares, Weight(%), market price (KRW)
No. (Number) Name Ticker Number of shares Weight(%) Market price (KRW)
1 Celltrion KR7068270008 451 11.31 103,730,000
2 SAMSUNG BIOLOGICS KR7207940008 50 9.24 84,700,000
3 ABL Bio KR7298380007 400 8.25 75,680,000
4 Alteogen KR7196170005 186 7.83 71,796,000
5 SCD KR7000250001 133 7.83 71,820,000
6 HLB KR7028300002 1,125 6.47 59,287,500
7 Yuhan KR7000100008 533 6.24 57,190,900
8 LCB KR7141080002 251 4.88 44,728,200
9 HanmiPharm KR7128940004 60 3.68 33,780,000
10 SKBP KR7326030004 261 3.12 28,631,700
11 PharmaResearch KR7214450009 64 2.35 21,568,000
12 ST Pharm KR7237690003 124 2.09 19,195,200
13 원화예금 KRD010010001 18,173,618 1.98 18,173,618
14 HANALL BIOPHARMA KR7009420001 338 1.91 17,474,600
15 L&C BIO KR7290650001 159 1.53 14,071,500
16 Celltrionph KR7068760008 197 1.52 13,947,600
17 CLASSYS KR7214150005 206 1.52 13,966,800
18 Hugel KR7145020004 51 1.38 12,673,500
19 SKBS KR7302440003 254 1.37 12,534,900
20 CHA Biotech KR7085660009 517 1.17 10,727,750
21 ORUM KR7475830006 91 1.09 10,037,300
22 Hanmi Science KR7008930000 194 1.01 9,292,600
23 GC Corp KR7006280002 53 0.98 8,978,200
24 SEEGENE KR7096530001 307 0.9 8,273,650
25 Pharmicell KR7005690003 535 0.86 7,869,850
26 HK inno.N KR7195940002 136 0.81 7,452,800
27 ILDONG PHARM KR7249420001 202 0.8 7,342,700
28 DAEWOONG PHARM KR7069620003 43 0.79 7,258,400
29 MedyTox KR7086900008 52 0.74 6,765,200
30 CHONGKUNDANG KR7185750007 76 0.73 6,733,600
31 CUREXO KR7060280005 278 0.59 5,454,360
32 Daewoong KR7003090008 188 0.52 4,747,000
33 HLBPHARMA KR7047920004 267 0.48 4,376,130
34 Binex KR7053030003 276 0.45 4,153,800
35 DongKook Pharm KR7086450004 226 0.44 4,063,480
36 ShinpoongPharm KR7019170000 317 0.44 4,010,050
37 EuBio KR7206650004 298 0.44 4,061,740
38 i-SENS KR7099190001 200 0.41 3,762,000
39 WONTECH KR7336570007 415 0.37 3,419,600
40 DENTIUM KR7145720009 63 0.34 3,087,000
41 SELVAS AI KR7108860008 227 0.31 2,826,150
42 Huons Global KR7084110006 52 0.3 2,719,600
43 Humedix KR7200670008 57 0.25 2,319,900
44 BioPlus KR7099430001 405 0.23 2,134,350
Investment notice
- The information provided on this website is based on reliable sources, but its accuracy and completeness are not guaranteed.
- Financial investment products are not protected by the Korea Deposit Insurance Corporation in accordance with the Depositor Protection Act, and a loss of investment principal may occur, which belongs to the investor.
- Past performance does not guarantee future profits.
- In the case of a collective investment scheme that invests in foreign securities, asset values may be lost due to risks caused by market, political, and economic conditions in the target country.
- Derivatives may lose all or a significant portion of the investment principal in a short period of time due to high price volatility, and there is a risk that the counterparty may not be able to fulfill the terms of the contract when investing in over-the-counter derivatives.
- Before investing, be sure to read the investment prospectus and contract recommendation document regarding the investment subject, redemption method, and fee.